Iris Grossman, Phd Email & Phone Number

Boston, Ma, Us

Boston, Ma, Us

Cambridge, Gb

Champion, supervise and manage the realization of Eleven's technology platforms into therapeutic assets (payloads and/or delivery vehicles) in the RNAi space, including R&D activities (Lead Selection & Optimization through to advanced clinical phases), IP and BD (partnerships and fundraising)

Cambridge, Gb

Cambridge, Gb

#ModuLight.bio develops life transforming medicines against devastating neurological disorders, such as drug-resistant focal Epilepsy, Parkinson’s disease, and severe neuropathic pain syndromes, by harnessing next-generation optogenetic solutions.

GROSS Advantage (formerly IsraGene) is a therapeutic strategy consultancy, serving the continuum of drug and diagnostic R&D, leveraging principles of human genetics, pharmacogenomics, biomarkers and digital-markers. GROSS Advantage is dedicated to the successful discovery and development of drugs worldwide, with a specific focus on the smooth and effective pursuit of Personalized Medicine, from novel indication and target ID through to drug/Dx R&D clinical trials. The company serves a wide-range of clients (VCs, Big Pharma, biotech and non-for-profits), providing a range of services that converge into cost-effective applications at every stage of the R&D pipeline. Particular expertise in bridging gaps between Israeli inventions/capabilities and global requirements/partners.

Zurich, Zurich, Ch

Zurich, Zurich, Ch

BC Platforms is a world leader in providing powerful genomic data management and analysis solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and healthcare information technologies. Our high performing genomic data management platform enables flexible data integration, secure analysis and interpretation of molecular and clinical information. BC Platforms’ vision is to revolutionize decision making in drug development to bring clinical benefits to patients. With twenty years of experience, BC Platforms truly is an expert in understanding the science of life.

Cambridge, Massachusetts, Us

Amide is at the forefront of a new biotech industry—fully synthetic proteins—thatboasts the combinatorial flexibility of small molecules, alongside the physiologicaladvantages of biologics. As the experts in this new field, we champion the proteintherapeutic 2.0 market.Amide was founded on the seminal inventions of Prof. Brad Pentelute enabling on-demandprotein synthesis including non-canonical chemical modifications - providingunique protein functionality (affinity, stability, bioavailability, cell membrane penetration)and reduced immunogenicity. Engineered synthetic proteins are coupled with ourartificial intelligence (AI) tools to predict performance characteristics of our assets at ascale unattainable with traditional methods for protein synthesis and post-translationalmodifications.

Cambridge, Massachusetts, Us

As CSO I served as the scientific face of the company, effectively leading, creating, and communicating R&D strategies across the scope of discovery and development activities and collaborations.CAMP4 Solves the riddle of gene regulation in order to develop effective and safe therapeutics. We discover and harness the mechanisms by which human cells respond to their environment through genomic output. CAMP4’s proprietary Gene Circuitry Platform rapidly predicts and validates druggable targets that affect a broad spectrum of therapeutic areas, including metabolic, kidney, muscle, neurological diseases and others.

Tel-Aviv, Il

Tuning drug discovery and development to the voices of patients, physicians and disease/therapy, ESD incorporates key functions that innovatively and creatively coordinates the right inputs as early as possible along the R&D pipeline: clinical pharmacology and pharmacometrics, personalized and predictive medicine, analytics and big data, translational development and a patient officer.

Tel-Aviv, Il

Employing cutting-edge biomarker research and Big Data analytics to innovatively inform and drive decision making that improves the benefit-risk profile of specialty, generic and technology offerings for patients, healthcare providers and payers. The unit generates strategic, evidence-based insight that informs Teva's entire pipeline, from discovery, through developmeny and into the market place.

Tel-Aviv, Il

The PMP unit is in charge of integrating biomarker research and treatment personalization into Teva's pipeline where a clear value-added proposition can offer patients and healthcare providers a clinically meaningful benefit/risk profile improvement. We support specialty and generic/repositioning pipelines through rigorous science and robust infrastructure, instilled when I joined the company and initiated this unit.

Tel-Aviv, Il

Cabernet Pharmaceuticals is a pharmacogenetics and project-management consultancy committed to helping its clients develop drugs with a greater chance of success.Our consultants bring deep experience in pharmacogenetics (PGx) to improving R&D pipeline management, securing regulatory approval, and enhancing market acceptance. The consultancy relationship, together with our service-provider partnerships, affords a flexible resource to meet the dynamic needs of pharmaceutical and biotechnology companies, clinical-research and managed-healthcare organizations, and academic institutions. Together with our clients, we strive to exploit the predictive power of PGx to deliver the right medicine at the right dose to the right patient.

Brentford, Middlesex, Gb

Pharmacogenetics lead for the Infectious Diseases therapeutic area, as well as program support for neurosciences and bio-pharmaceutics

Tel-Aviv, Il

Durham, North Carolina, Us

B.Sc. & Direct Phd, Medicine / Pharmacogenetics

Boardroom Ready, Executive Women In Bio (Ewib), Business

Executive Healthtech Program

Postgraduate Degree, Genome Sciences/Genomics

Phd (On-Site Joint Mentorship, Degree From The Technion), Pharmacogenetics And Population Genetics